References
Kotler, M.N.; Berman, L. and Rubenstein, A.H.: Hypoglycaemia precipitated by propranolol. Lancet 2: 1389–1390 (1966).
Wray, R. and Sutcliffe, S.B.J.: Propranolol-induced hypoglycaemia and myocardial infarction. British Medical Journal 2: 592 (1972).
Abramson, E.A.; Arky, R.A. and Woeber, K.A.: Effects of propranolol on the hormonal and metabolic responses to insulin-induced hypoglycaemia. Lancet 2: 1386–1388 (1966).
Skinner, D.J. and Misbin, R.I.: Uses of propranolol. New England Journal of Medicine 293: 1205 (1975).
Podolsky, S. and Pattavina, CG.: Hyperosmolar nonketotic diabetic coma: a complication of propranolol therapy. Metabolism 22: 685–693 (1973).
Reveno, W.S. and Rosenbaum, H.: Propranolol hypoglycaemia. Lancet 1: 920 (1968).
Fitzgerald, J.D.: Effects of propranolol on blood sugar, insulin and free fatty acids. Diabetologia 5: 339 (1968).
Davidson, M.McD.; Corrall, R.J.M.; Shaw, T.R.D. and French, E.B.: Observations in man of hypoglycaemia during selective and nonselective beta-blockade. Scottish Medical Journal 22: 69–72 (1976).
Deacon, S.P. and Barnett, D.: Comparison of atenolol and propranolol during muscular-induced hypoglycaemia. British Medical Journal 2: 272–273 (1976).
Newman, R.J. British Medical Journal 2: Comparison of propranolol, metoprolol and acebutolol on insulin-induced hypoglycaemia. Brit M. J. 2: 447–449 (1976).
Linton, S.P.; Scott, P.H. and Kendall, M.J.: Blood sugar and beta blockers. British Medical Journal 2: 877–878 (1976).
Deacon, S.P.; Karunanayaka, A. and Barnett, D.: Acebutolol, atenolol and propranolol and metabolic responses to acute hypoglycaemia in diabetics. British Medical Journal 2: 1255–1257 (1977).
Garber, A.J.; Cryer, P.E.; Santiago, J.V.; Haymond, M.W.; Pagliara, A.S. and Kipuis, D.M.: The role of the adrenergic mechanisms in the substrate and hormonal response to insulininduced hypoglycaemia in man. The Journal of Clinical Investigation 58: 7–15 (1976).
Ajlouni, K.; Sill, A.J. and Hagen, T.C.: Glucoregulation of prolactin secretion. Diabetes 25: Suppl. 1,121 (1976).
Campbell, L.V.; Kraegen, E.W. and Lazarus, L.: Defective blood glucose counter regulation in diabetics is a selective form of autonomic neuropathy. British Medical Journal 2: 1527–1529 (1977).
Lloyd-Mostyn, R.H. and Oram, S.: Modification by propranolol of cardiovascular effects of induced hypoglycaemia. Lancet 2: 1213–1215 (1975).
Johnsson, G.: Influence of metoprolol and propranolol on hemodynamic effects induced by adrenaline and physical work. Acta Pharmacologica et Toxicologica 36: Suppl. 5, 59–68 (1975).
Herwaarden, C.L.A.; Binkhorst R.A.; Fennis, J.F.M. and van’t Laar, A.: Effects of adrenaline during treatment with propranolol and metoprolol. Lancet 1: 1029 (1977).
McMurtry, R.L.: Propranolol, hypoglycaemia and hypertensive crisis. Annals of Internal Medicine 80: 669–670 (1974).
Waal-Manning, H.J.: Metabolic effects of β-adrenoreceptor blockers. Drugs 11 (Suppl. 1): 121–126 (1976).
Ekberg, G. and Hansson, B.C.: Glucose tolerance and insulin release in hypertensive patients treated with the cardio-selective β-receptor blocking agent metoprolol. Acta Medica Scandinavica 202: 393–397 (1977).
Frohlich, E.D.; Tarazi, R.C. and Dustan, Harriet P.: Peripheral arterial insufficiency: a complication of beta-adrenergic blocking therapy. Journal of the American Medical Association 208: 2471–2472 (1969).
Marshall, A.J.; Roberts, C.J. and Barritt, D.W.: Raynaud’s phenomenon as a side effect of beta-blockers. British Medical Journal 1: 1498–1499 (1976).
Rand, J.J.; Law, M.; Story, D.F. and McCulloch, M.W.: Effects of β-adrenoceptor blocking drugs on adrenergic transmission. Drugs 11: (Suppl. I); 134–143 (1976).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Waal-Manning, H.J. Can β-Blockers be Used in Diabetic Patients?. Drugs 17, 157–160 (1979). https://doi.org/10.2165/00003495-197917030-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-197917030-00002